San Diego, CA, United States of America

Ved Prakash Pathak



Average Co-Inventor Count = 10.8

ph-index = 5

Forward Citations = 275(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ved Prakash Pathak

Introduction

Ved Prakash Pathak is a notable inventor based in San Diego, California. He has made significant contributions to the field of kinase inhibitors, holding a total of nine patents. His work focuses on developing compounds that can effectively inhibit various kinases, which play crucial roles in cellular signaling and disease processes.

Latest Patents

Among his latest patents are the bi-aryl meta-pyrimidine inhibitors of kinases. This invention provides biaryl meta-pyrimidine compounds capable of inhibiting kinases, including members of the Jak kinase family and various other specific receptor and non-receptor kinases. Another significant patent is for benzotriazine inhibitors of kinases, which includes benzotriazine compounds that can inhibit kinases, such as members of the Src kinase family and other specific receptor and non-receptor kinases.

Career Highlights

Throughout his career, Ved Prakash Pathak has worked with prominent companies in the pharmaceutical industry, including Targegen, Inc. and Agouron Pharmaceuticals, Inc. His expertise in the development of kinase inhibitors has positioned him as a valuable asset in the field of drug discovery and development.

Collaborations

Some of his notable coworkers include Glenn Noronha and Chi Ching Mak. Their collaborative efforts have contributed to the advancement of research in kinase inhibitors and related therapeutic areas.

Conclusion

Ved Prakash Pathak's innovative work in the development of kinase inhibitors has made a significant impact in the pharmaceutical industry. His contributions continue to pave the way for new therapeutic options in treating various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…